Determination of CYP2D6 Gene Alleles by the CYP450 Probe Array Using the Affymetrix GeneChip System: Comparison with Sequencing Results

Drug Metabolism and Pharmacokinetics

Volumn 17, Issue 2, 2002, Pages 157-160

  Ishida, Seiichi ^a   Ozawa, Shogo ^a   Soyama, Akiko ^b   Saito, Yoshiro ^b   Murayama, Norie ^c   Saeki, Mayumi ^c  

^a Division of Pharmacology   (Japan)

^b Division of Biochemistry and Immunochemistry   (Japan)

^c NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Affymetrix GeneChip; alleles; CYP2D6; probe array; sequencing; single nucleotide polymorphisms (SNP)

Indexed keywords

EID: 33645081095     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.17.157     Document Type: Article

References (6)

1. Nishida, Y., Fukuda, T., Yamamoto, I. and Azuma, J.: CYP2D6 genotypes in a Japanese population: low frequency of CYP2D6 gene duplication but high frequency of CYP2D6*10. Pharmacogenetics, 10: 567-570 (2000).
2. Nakamura, T., Saito, Y., Murayama, N., Saeki, M., Soyama, A., Sai, K., Ozawa, S. and Sawada, J.-I.: Apparent low frequency of sequence variability within the proximal promoter region of the cytochrome P450 (CYP) 3A5 gene in established cell lines from Japanese individuals. Biol. Pharm. Bull., 24: 954-957 (2001).
3. Steen, V. M., Andreassen, O. A., Daly, A. K., Tefre, T., Borresen, A. L., Idle, J. R. and Gulbrandsen, A. K.: Detection of the poor metabolizer-associated CYP2D6(D) gene deletion allele by long-PCR technology. Pharmacogenetics, 5: 215-223 (1995).
4. Hersberger, M. Marti-Jaun, J., Rentsch, K. and Hanseler, E.: Rapid detection of the CYP2D6*3, CYP2D6*4, and CYP2D6*6 alleles by tetra-primer PCR? and of CYP2D6*5 allele by multiplex long PCR. Clin. Chem., 46: 1072-1077 (2000).
5. Johansson, I., Oscarson, M., Yue, Q. Y., Bertilsson, L., Sjoqvist, F. and Ingelman-Sundberg, M.: Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation. Mol. Pharmacol., 46: 452-459 (1994).
6. Gaedigk, A., Blum, M., Gaedigk, R., Eichelbaum, M. and Meyer, U. A.: Deletion of the entire cytochrome P450 CYP2D6 gene as a cause of impaired drug metabolism in poor metabolizers of the debrisoquine/sparteine polymorphism. Am. J. Hum. Genet., 48: 943-950 (1991).